Furthermore, the glucose levels in the former group returned to baseline within 20 min, while it took over 30 min in the latter group (Fig
Among them, anti-obesity drugs have high compliance rates and cause noticeable short-term effects in reducing obese levels
doi: 10.1089/dia.2014.0188
In one of the focus groups, there was no disagreement when one participant asked, [d]oes it feel almost inevitable that those drugs are going to become part of our formulary? Our insurance provider, Cigna told us that within the next 9 to 12 months, theres really not going to be a choice, that all insurance companies are probably going to be covering GLP-1s for weight loss. Occupational health manager, large manufacturer The use of GLP-1 drugs for weight loss is still new for many employers, and many are not sure how or whether they can manage the benefit
For example, a nutritional goal for a PBH patient might be to consume food products that provide a maximum of 30 g carbohydrates per serving size, or cereals with a certain carbohydrate-to-fiber ratio
Differentiation amongst these agents is important, and there are several factors that will make assets from smaller companies attractive: 1) oral and infrequent dosing regimens, 2) ability to improve cardiometabolic outcomes along with weight loss, and 3) reduced GI side effects